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Introduction
The use of vasopressor was common in medical intensive
care unit (MICU). Due to the lack of conclusive evidence
in superiority in efficacy among various types of vasopres-
sors, the choice of vasopressor use mainly depends on the
physician preference.
Objectives
This study aims to describe the prevalence of vasopressor
use and the trend in the use of each vasopressor medica-
tion in MICU over the past 7 years.
Methods
This is a descriptive study conducted at a tertiary referral
hospital. All MICU admissions at our institution between
January 2007 and December 2013 were included in
this study. The use of vasopressor within given ICU day
(12.00 am - 11.59 pm) during ICU stay was reviewed.
Vasopressors were defined as the continuous intravenous
administration of norepinephrine, epinephrine, dopamine,
phenylephrine, or vasopressin regardless of duration and
dosage. The use of each vasopressor was reported as the
vasopressor utilization index (VUI), using the following
formula Vasopressor utilization index (VUI) = The total
number of ICU days on a given vasopressor/The total
number of ICU days on any vasopressor.
Results
A total of 16,863 unique patients had 17,164 MICU admis-
sions in the course of study, (55,391patient*ICU day).Out
of 7,739 ICU days with vasopressor use, norepinephrine
was used for 6,414 (83%), vasopressin for 1,960 (25%), phe-
nylephrine for 772 (10%), dopamine for 623 (8%), and epi-
nephrine for 323 (4%). From 2007 through 2013, there
was an increasing trend in the use of norepinephrine
(VUInorepinephrine was 0.69 in 2007 and 0.91 in 2013)
and an slight increasing trend in the use of epinephrine
(VUIepinephrine was 0.01 in 2007 and 0.06 in 2013).
There was a decreasing trend in the use of dopamine
(VUIdopamine was 0.15 in 2007 and 0.03 in 2013), vasopres-
sin (VUIvasopressin was 0.42 in 2007 and 0.22 in 2013), and
a slight downward trend in the use of phenylephrine.
Conclusions
Norepinephrine is the most commonly used vasopressor
in MICU. The use of norepinephrine and epinephrine
are in upward trajectory.
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